Vir Biotechnology, Inc.

NasdaqGS:VIR Stock Report

Market Cap: US$1.3b

Vir Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:VIR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Apr 24SellUS$690,365Marianne De BackerIndividual72,995US$9.46
01 Apr 24SellUS$27,251Ann HanlyIndividual2,711US$10.05
27 Mar 24SellUS$59,404Sung LeeIndividual6,008US$9.89
22 Feb 24SellUS$100,737George ScangosIndividual10,028US$10.05
22 Feb 24SellUS$146,344Phillip PangIndividual14,568US$10.05
22 Feb 24SellUS$123,521Ann HanlyIndividual12,296US$10.05
16 Feb 24SellUS$34,006Phillip PangIndividual3,321US$10.24
16 Feb 24SellUS$111,386George ScangosIndividual10,878US$10.24

Insider Trading Volume

Insider Buying: VIR insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of VIR?
Owner TypeNumber of SharesOwnership Percentage
Private Companies25,5650.0188%
State or Government45,2780.0333%
Individual Insiders7,102,4645.22%
Public Companies8,550,9546.28%
General Public16,831,88612.4%
VC/PE Firms29,600,70421.8%
Institutions73,901,82954.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 76.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.3%
SoftBank Investment Advisers (UK) Limited
16,684,041US$163.0m0%0.8%
12.2%
BlackRock, Inc.
16,563,612US$161.8m-1.78%no data
9.49%
Arch Venture Partners, L.P.
12,916,663US$126.2m0%9.43%
9.1%
The Vanguard Group, Inc.
12,375,355US$120.9m0.64%no data
6.28%
GSK plc
8,550,954US$83.5m0%no data
5.08%
State Street Global Advisors, Inc.
6,912,082US$67.5m-3.64%no data
2.9%
Baillie Gifford & Co.
3,947,065US$38.6m-0.47%0.02%
2.75%
George Scangos
3,743,298US$36.6m0%no data
2.23%
Citadel Advisors LLC
3,037,948US$29.7m3,540%0.03%
2.04%
AllianceBernstein L.P.
2,781,049US$27.2m-4.03%0.01%
1.39%
Geode Capital Management, LLC
1,886,396US$18.4m5.16%no data
1.3%
Bridgeway Capital Management, LLC
1,767,308US$17.3m2.11%0.28%
1.15%
Bill & Melinda Gates Foundation Trust
1,559,142US$15.2m0%0.03%
1.03%
Morgan Stanley, Investment Banking and Brokerage Investments
1,406,415US$13.7m111%no data
0.96%
Vicki Sato
1,309,324US$12.8m-0.46%no data
0.95%
Renaissance Technologies LLC
1,294,600US$12.6m-4.42%0.02%
0.83%
Citigroup Inc.,Banking and Securities Investments
1,124,731US$11.0m446%0.01%
0.69%
Northern Trust Global Investments
937,304US$9.2m-6.13%no data
0.61%
Charles Schwab Investment Management, Inc.
829,311US$8.1m10.1%no data
0.59%
BNY Mellon Asset Management
806,929US$7.9m11.9%no data
0.57%
D. E. Shaw & Co., L.P.
769,144US$7.5m-12.6%0.01%
0.53%
Eaton Vance Management
717,942US$7.0m0%no data
0.45%
UBS Asset Management AG
618,239US$6.0m68.9%no data
0.44%
Robert Taylor Nelsen
604,014US$5.9m1.07%no data
0.43%
Dimensional Fund Advisors LP
579,126US$5.7m23.7%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.